Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion type Assertion NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_head.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion wasGeneratedBy ECO_0000203 NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion wasDerivedFrom befree-20140225 NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion SIO_000772 16865277 NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion evidence source_evidence_literature NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.